Inflammatory Breast Cancer: 10-Year Follow-up of a Trial of Surgery, Chemotherapy, and Allogeneic Tumor Cell/BCG Immunotherapy
作者:
WisemanCharles L.,
期刊:
Cancer Investigation
(Taylor Available online 1995)
卷期:
Volume 13,
issue 3
页码: 267-271
ISSN:0735-7907
年代: 1995
DOI:10.3109/07357909509094460
出版商: Taylor&Francis
数据来源: Taylor
摘要:
A 10-year follow-up analysis has been performed on the cohort of 13 previously reported inflammatory breast cancer patients treated with chemotherapy, surgery, and allogeneic tumor cell/BCG vaccine. Follow-up of this duration is uncommon in the literature. Data indicate an apparent plateau of the survival curve at about 5 years, with 4 of 13 patients (31%) still alive after 10 years. Also noted is a long-term survival of an of-protocol padient with metastatic breast cancer treated with chemotherapy and vaccine. Although the role of vaccine cannot be directly determined from this study, this trial did demonstrate that long-term survival is a feasible goal for a significant fraction of patients with inflammatory breast cancer.
点击下载:
PDF (382KB)
返 回